AbC-19™ is a SARS-CoV-2 (COVID-19) rapid neutralising antibody test solution that produces results in 20 minutes and creates an antibody certificate via a smartphone app. This flexible, easy solution shows confirmation to individuals who have developed IgG neutralising antibodies following COVID-19 infection or vaccination.
By leveraging the fact that COVID-19 neutralising antibodies are an important factor in the determination of a person’s immunity status, we have developed the flexible AbC-19™ antibody testing solution which includes a rapid test that is reliable and accurate:
Sensitivity: 98.03%, Specificity: 99.56%
This is paired with an easy-to-use mobile app which allows a trained professional to generate an antibody certificate for storing on a person’s smartphone.
AbC-19™ IgG LFD successfully used semi-quantitively to monitor vaccine responses to variant proteins.
Read this update to learn more.
AbC-19TM Rapid Test further performance data announcement
Click the button below to read the further performance data for the AbC-19TM Rapid Test.
About UK-RTC
The UK-Rapid Test Consortium (UK-RTC) was set up by Abingdon Health to bring together scientists and medical device manufacturers to be able to deliver millions of test kits as quickly as possible following the SARS-CoV-2 outbreak. By working together, some of the UK’s leading medical technology companies will deliver more volume more quickly to help fight COVID-19.
We would be really pleased to chat to you – as an initial step, please fill out the form below and a member of our team will contact you.